Clinical Trial Update: Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

View source ↗

Summary

Pfizer-sponsored clinical trial update on tofacitinib in adults with moderate to severe ulcerative colitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Status: COMPLETED